Levetiracetam Tolife

Levetiracetam, the active ingredient in Levetiracetam Tolife, is an Anticonvulsant presented as a tablet for oral use. It is employed to treat various seizure types in patients with epilepsy, including partial seizures, generalized tonic‑clonic seizures, and myoclonic seizures, helping to reduce the frequency and severity of episodes.

GNH USA supplies Levetiracetam Tolife as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements. The product complies with European Union pharmaceutical standards.

Levetiracetam is an antiepileptic drug that modulates neuronal excitability in seizure disorders.

- Partial seizures: reduces seizure frequency and intensity in patients with focal onset epilepsy. - Generalized tonic-clonic seizures: helps control convulsive episodes in primary generalized epilepsy. - Myoclonic seizures: diminishes rapid muscle jerks associated with juvenile myoclonic epilepsy.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: increased tiredness or lack of energy. - Headache: mild to moderate cranial pain. - Irritability: mood changes or increased agitation. - Nausea: upset stomach, sometimes with vomiting.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood disorders: depression, anxiety, or suicidal thoughts. - Hematologic abnormalities: low blood cell counts. - Hepatic dysfunction: elevated liver enzymes. - Stevens‑Johnson syndrome: severe skin blistering.

When prescribing Levetiracetam, clinicians should consider several safety and handling measures. - Renal impairment: adjust dose in patients with reduced kidney function. - Psychiatric history: monitor for mood changes or suicidal ideation. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy: category B, but discuss risks and benefits with the patient. - Elderly patients: start at lower dose and titrate slowly. - Store at room temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may decrease levetiracetam plasma levels. - Phenobarbital: can reduce levetiracetam exposure. - Rifampin: induces metabolism, lowering drug concentration.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam levels, monitor for toxicity. - Opioids (e.g., tramadol): additive CNS depression risk. - Alcohol: enhances sedation and dizziness. - Oral contraceptives: potential reduced effectiveness, advise alternative contraception.